Investment Q&A

Q: Hi Peter and Gang,
I would appreciate your thoughts on Biomarin Pharmaceutical Inc. listed on NASDAQ either as a trade or a long-term hold.
Thanks,

Q: Re my Q yesterday,I have a 2.5% position @ $17.74.Should I buy more at current price.Txs for U usual great services & views

Q: Will Covalon ever catch a bid?
When a high flying Junior falls from grace,the pendulum all too often swings the other way.

Q: Hello

Why is Covalon Technologies down so much?

Thanks
Amy

Q: I hate it when companies do “bought deals” at prices lower that market price. I understand why they do it but it feels like a blindside. Companies do not care for the shareholders.

The little guy always feels the pain and then the stock is dead money for several months until the deal is closed or longer.

5I is just guessing they will buy another company, no one knows for sure.

My questions are:

1. Why would SIS-t have to “clean up the balance sheet” prior to buying another company? It’s such a small deal. Is there something wrong with the balance sheet?
They did not do this for previous purchases. (H.E.S. Elevator or was it Visilift) or did they, I may have missed it? Is there another reason for this deal? Isn’t the issue for more funds normally done at the same time or after a purchase instead of before?

2. SIS-t will be “dead money now”. Do you not believe that when a stock becomes “dead money” it would it not be better to place capital elsewhere until the stock moves up?

3. For bought deals, the little guy can’t participate in these types of issues if managing a self-directed account. How unfair is this?

4. I don’t usually look at financial reports for companies but this looks suspect.

The Annual Balance Sheet for Dec 31, 2017 shows:
“ Intangibles” = $100.49C$Mil. versus less than 12.05 mil in previous years

Why is it much higher than the preceding 3 years? Can you explain what this is? And should we be worried?

Q: As a current holder of SIS(2.5% @ $17.74 p/p),I was not thrilled at all with the $16.60 Bought Deal announced last night,resulting in a loss of 0.66 to $16.83 today.Please advise if I should buy more @ this price.Thanks for u usual great views & services

Q: What do you see for the long term future of CHH?

Q: Hi 5i,

Thoughts on the offering by SIS. Is it rare for insiders to participate in an offering like this?

Thank you,
David

Q: Why would not GUD take a run at TH....both Montreal based cos. TH has 2 FDA approved drugs, one of which is life-saving and the market has not given this co a much better valuation. Plus TH has about 32 mil in cash and little debt!

Q: Hi, Peter, Ryan can you comment on the consolidation of the shares of PLI. I received the voting instruction form today. I know 5i sold its shares but for those who held on what would your recommendation be at this point or what would be the best thing to do. Thanks, Nick

Q: I have noticed this emerging biotech stock has been moving up nicely since they did a financing.
Can I have your thoughts.
Regards

Q: What do you think of the acquisition made by SIS?

Q: I believe you have doubts about these two but which one has the sketchy management ?? Could a case be made for holding either or both? Thanx Robbie

Q: Regarding GUD and ENDP Asked by Serge and others waiting for GUD to make a move. Considering debt load, Enbridge merged with Spectra, Davis and Henderson bought Harland Financial. What happened to ENB share price and where is D&H today. Could Knight be biting off too much as well if they were to move on ENDP considering the debt they would inherit?
Quote: "ENDP has more than $7B in debt and less than $600M in cash flow in the last 12 months. The stock is down 50% in a year. Interest expenses of $488M last year ate up nearly all of its total cash flow. Earnings are lower than they were 8 years ago."

Q: Would you have a comment on Largo LGO & Fennex Pharma FRX ? RAK

Q: COV seems to be in freefall, down about 50 percent from recent highs. Is there some issue with it or just the market. Are you still comfortable with this in the portfolio?

Q: Do you have any information or an opinion on this US company?

Phil

Q: What's your view on Bristol Myers Squibb's potential as a longterm investment?
Thanks.

Q: Hi team !
I have been holding pjp-n for almost 3 years and it just keep going down.
I am about 24% in the red. I hold in my TFSA and it is 14% of that account.
Any hope for this ETF to recover soon ? Or would you advise to take my lost and invest in something else with a good growth potential ? I already hold SIS-T
Thanks for your help
Jacques

Q: Mr. Hodson, could it be that GUD is precluded from buying back ENDO by virtue of a non-compete clause for 3 years ? If so, one would have to abide by that clause. It would no be possible to avoid such clause. Therefore, one would have to await the passage of such time, as this would be binding for both parties. Does that makes sense ?